GLP Watchdog

MEDVi vs Ro

MEDVi has an open FDA warning letter dated February 20, 2026. Ro has none. No price lines up like for like: MEDVi and Ro publish prices for different products.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

MEDVi / Ro

MEDVi logo

MEDVi

7.7/10

Ro logo

Ro

7.4/10

FDA warning letters
None on record
Pharmacy
Lowest standing price
$199/moCompounded semaglutide injection
$149/moBrand-name semaglutide pill, medication only, membership extra
States
All 50 states
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit MEDVi
Visit Ro

Neither MEDVi nor Ro pays us. Links to them earn nothing. Scores: MEDVi 7.7, Ro 7.4. How we are paid

What the record shows

  1. 01

    MEDVi has an open FDA warning letter dated February 20, 2026. Ro has none.

  2. 02

    MEDVi names three pharmacies, all 503A. Ro sells brand-name medication only.

  3. 03

    No price lines up like for like: MEDVi and Ro publish prices for different products.

  4. 04

    Only MEDVi lists a price for compounded semaglutide injection. Only Ro lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

MEDVi

Ro

Compounded semaglutide injection

$199/mo

$2,388 a year

Not sold or not priced
Brand-name semaglutide pen
Not sold or not priced

$199/mo

medication only, membership extra; not compared

Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Brand-name semaglutide pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Foundayo (orforglipron) pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Price includes
Medication, clinician visits, shipping, coaching
Clinician visits, labs, coaching
Billed separately
Not stated
Medication
Cancel any time
Yes, stated
Yes, stated
Minimum term
None; billed monthly
None on the monthly plan; 3, 6 and 12-month plans are prepaid
Refunds
Full refund if medically disqualified, or if canceled within 72 hours before any service; none for months already billed
Membership fees are not refunded; the $39 first month is refunded if you are not eligible
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. MEDVi: October 25, 2026. Ro: October 31, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for MEDVi

7.7/10
  • Sells compounded semaglutide injection, which Ro does not price
  • Open FDA warning letter, February 20, 2026
Visit MEDVi

The case for Ro

7.4/10
  • No FDA warning letter on record
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which MEDVi does not price
  • Price leaves out medication
  • Lowest price covers the medication only, with a separate membership on top
Visit Ro

Scores

MEDVi 7.7 · Ro 7.4 out of 10. Six weighted parts.

Value25%

5.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.0A
vs
B
9.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

8.5A
vs
B
5.5

The score is the same formula for every seller. Payment does not enter it. Method

MEDVi vs Ro: questions

MEDVi has an open FDA warning letter dated February 20, 2026. Ro has none. Letters are matched to a seller by company, domain and address, never by a similar name.
MEDVi names three pharmacies, all 503A. Ro sells brand-name medication only. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like: MEDVi and Ro publish prices for different products. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
MEDVi states you can cancel at any time; refunds: full refund if medically disqualified, or if canceled within 72 hours before any service; none for months already billed. Ro states you can cancel at any time; refunds: membership fees are not refunded; the $39 first month is refunded if you are not eligible.
Neither MEDVi nor Ro pays us. Links to them earn nothing. Scores: MEDVi 7.7, Ro 7.4.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks